Literature DB >> 6772782

Oligohydramnios and transient neonatal anuria: a possible association with the maternal use of prostaglandin synthetase inhibitors.

B Cantor, T Tyler, R M Nelson, G H Stein.   

Abstract

The chronic use of prostaglandin synthetase inhibitors is reported in a pregnant patient with severe juvenile rheumatoid arthritis. Aspirin and indomethacin, along with corticosteroids, were required to prevent significant progression of the disease. Pregnancy was complicated by oligohydramnios and intrauterine growth retardation. The infant suffered transient anuria. The effects of prostaglandin synthetase inhibitors on renal vascular function is reviewed, and a possible association between the chronic ingestion of these drugs and compromised renal function in the newborn is pointed out.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772782

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  [Not Available].

Authors:  K Strasser
Journal:  Schmerz       Date:  1988-06       Impact factor: 1.107

2.  Fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy.

Authors:  S Campbell; A Clohessy; C O'Brien; S Higgins; M Higgins; F McAuliffe
Journal:  Obstet Med       Date:  2017-01-29

Review 3.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 5.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

6.  Neonatal renal dysfunction and intrauterine exposure to prostaglandin synthesis inhibitors.

Authors:  U Simeoni; J Messer; P Weisburd; J Haddad; D Willard
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.